Affordable Access

International study of ketanserin in Raynaud's phenomenon.

Authors
Type
Published Article
Journal
The American Journal of Medicine
0002-9343
Publisher
Elsevier
Publication Date
Volume
87
Issue
3
Pages
264–268
Identifiers
PMID: 2672807
Source
Medline
License
Unknown

Abstract

Ketanserin significantly improves the subjective symptoms of patients with primary or secondary Raynaud's phenomenon and is an appropriate agent to use in this disease when conservative measures fail.

Statistics

Seen <100 times